Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Kobayashi

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Journal of Atherosclerosis and Thrombosis|March 11, 2015
How Does Bezafibrate Affect the Plasma LDL Cholesterol Levels?Junji Kobayashi
Journal of Atherosclerosis and Thrombosis|April 1, 2021
Pitavastatin versus Atorvastatin: Potential Differences in their Effects on Serum Lipoprotein Lipase and Cardiovascular DiseaseJunji Kobayashi
Journal of Atherosclerosis and Thrombosis|April 7, 2004
Pre-heparin lipoprotein lipase massJunji Kobayashi
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 27, 2007
[Statins]Junji Kobayashi
Journal of Atherosclerosis and Thrombosis|March 1, 2019
Which is the Best Predictor for the Development of Atherosclerosis Among Circulating Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase?Junji Kobayashi
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 20, 2011
[Effect of statin treatment on metabolic syndrome]Junji Kobayashi
Journal of Atherosclerosis and Thrombosis|February 16, 2016
Optimal Management Target for Non-High-Density Lipoprotein CholesterolHayato Tada, Junji Kobayashi
Annals of Clinical Biochemistry|May 22, 2015
Lipoprotein lipase and atherosclerosisJunji Kobayashi, Hiroshi Mabuchi
European Journal of Internal Medicine|June 22, 2005
Severely elevated serum triglycerides in a case of heterozygous familial hypercholesterolemia with the 317 cysteine to serine mutation in the LDL receptor geneJunji Kobayashi, Hiroshi Mabuchi
Expert Opinion on Therapeutic Patents|October 8, 2013
Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178Katsuyuki Nakajima, Junji Kobayashi
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Journal of Atherosclerosis and Thrombosis|March 11, 2015
How Does Bezafibrate Affect the Plasma LDL Cholesterol Levels?Junji Kobayashi
Journal of Atherosclerosis and Thrombosis|April 1, 2021
Pitavastatin versus Atorvastatin: Potential Differences in their Effects on Serum Lipoprotein Lipase and Cardiovascular DiseaseJunji Kobayashi
Journal of Atherosclerosis and Thrombosis|April 7, 2004
Pre-heparin lipoprotein lipase massJunji Kobayashi
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 27, 2007
[Statins]Junji Kobayashi
Journal of Atherosclerosis and Thrombosis|March 1, 2019
Which is the Best Predictor for the Development of Atherosclerosis Among Circulating Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase?Junji Kobayashi
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 20, 2011
[Effect of statin treatment on metabolic syndrome]Junji Kobayashi
Journal of Atherosclerosis and Thrombosis|February 16, 2016
Optimal Management Target for Non-High-Density Lipoprotein CholesterolHayato Tada, Junji Kobayashi
Annals of Clinical Biochemistry|May 22, 2015
Lipoprotein lipase and atherosclerosisJunji Kobayashi, Hiroshi Mabuchi
European Journal of Internal Medicine|June 22, 2005
Severely elevated serum triglycerides in a case of heterozygous familial hypercholesterolemia with the 317 cysteine to serine mutation in the LDL receptor geneJunji Kobayashi, Hiroshi Mabuchi
Expert Opinion on Therapeutic Patents|October 8, 2013
Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178Katsuyuki Nakajima, Junji Kobayashi
Pageof 16